Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | -2,481 | 5,152 | 3,269 | 2,905 | 3,231 |
| Gross Profit | -2,481 | 5,152 | 3,269 | 2,905 | 3,231 |
| Operating Expenses | 30,781 | 29,842 | 30,444 | 30,053 | 28,469 |
| Operating Income | -33,262 | -24,690 | -27,175 | -27,148 | -25,238 |
| Other Income | 2,608 | 2,145 | 1,520 | 1,037 | 586 |
| Pre-tax Income | -30,654 | -22,545 | -25,655 | -26,111 | -24,652 |
| Net Income Continuous | -30,654 | -22,545 | -25,655 | -26,111 | -24,652 |
| Net Income | $-30,654 | $-22,545 | $-25,655 | $-26,111 | $-24,652 |
| EPS Basic Total Ops | -0.69 | -0.53 | -0.65 | -0.66 | -0.63 |
| EPS Basic Continuous Ops | -0.69 | -0.53 | -0.65 | -0.66 | -0.63 |
| EPS Diluted Total Ops | -0.69 | -0.53 | -0.65 | -0.66 | -0.63 |
| EPS Diluted Continuous Ops | -0.69 | -0.53 | -0.65 | -0.66 | -0.63 |
| EBITDA(a) | $-32,797 | $-24,061 | $-26,717 | $-26,862 | $-25,129 |